Target Name: EIF1AX-AS1
NCBI ID: G100874078
Review Report on EIF1AX-AS1 Target / Biomarker Content of Review Report on EIF1AX-AS1 Target / Biomarker
EIF1AX-AS1
Other Name(s): EIF1AP1 | EIF1AX antisense RNA 1 | EIF-1A | EIF-4C | EIF4C | EIF1A

EIF1AX-AS1: A Potential Drug Target and Biomarker

EIF1AX-AS1, also known as EIF1AX, is a protein that is expressed in various tissues of the body, including the brain, heart, and skeletal muscles. Its function is not well understood, but it is known to play a role in the regulation of cellular processes that are essential for muscle function and growth. There is also evidence to suggest that EIF1AX-AS1 may have potential as a drug target or biomarker.

The EIF1AX Family

The EIF1AX family is a group of proteins that share a common structural domain known as the EIF1AX domain. This domain is characterized by a specific sequence that is composed of multiple amino acids that are involved in a protein-protein interaction network. The EIF1AX domain is also known as the HSP70-like domain, and it is thought to play a role in the regulation of protein-protein interactions and the formation of protein aggregates.

EIF1AX-AS1: Structure and Expression

EIF1AX-AS1 is a 21-kDa protein that is expressed in various tissues of the body, including the brain, heart, and skeletal muscles. It is highly conserved, with a calculated pI of 11.0 and a predicted localization in the cytoplasm of cells. EIF1AX-AS1 is associated with various cellular processes that are essential for muscle function and growth, including the regulation of muscle protein synthesis and the control of muscle cell growth.

Expression of EIF1AX-AS1

EIF1AX-AS1 is expressed in a variety of tissues and cells, including muscle cells, nerve cells, and blood vessels. It is also expressed in the brain, where it is thought to play a role in the regulation of neural signaling and muscle function. EIF1AX-AS1 is also expressed in heart muscle, skeletal muscles, and other tissues, where it may be involved in the regulation of muscle contractions and growth.

Drug Target Potential

EIF1AX-AS1 is a potential drug target due to its involvement in various cellular processes that are important for muscle function and growth. Its high conservation and predicted localization in the cytoplasm make it a promising candidate for drug targeting. Additionally, its association with muscle protein synthesis and growth may make it a target for muscle-building drugs.

Biomarker Potential

EIF1AX-AS1 may also have potential as a biomarker for various muscle-related conditions, such as muscle dystrophy, muscle weakness, and muscle overload. Its involvement in the regulation of muscle protein synthesis and growth may make it a useful biomarker for muscle disorders that are characterized by muscle weakness or dysfunction.

Conclusion

In conclusion, EIF1AX-AS1 is a protein that is expressed in various tissues of the body and is thought to play a role in the regulation of cellular processes that are essential for muscle function and growth. Its high conservation and predicted localization in the cytoplasm make it a promising candidate for drug targeting. Additionally, its association with muscle protein synthesis and growth may make it a target for muscle-building drugs, and its potential as a biomarker for various muscle-related conditions makes it a valuable tool for the study of muscle biology. Further research is needed to fully understand the function of EIF1AX-AS1 and its potential as a drug target and biomarker.

Protein Name: EIF1AX Antisense RNA 1

The "EIF1AX-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF1AX-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EIF1AXP1 | EIF1AY | EIF1B | EIF1B-AS1 | EIF1P3 | EIF2 complex | EIF2A | EIF2AK1 | EIF2AK2 | EIF2AK3 | EIF2AK3-DT | EIF2AK4 | EIF2B1 | EIF2B2 | EIF2B3 | EIF2B4 | EIF2B5 | EIF2D | EIF2S1 | EIF2S2 | EIF2S2P3 | EIF2S2P4 | EIF2S3 | EIF3A | EIF3B | EIF3C | EIF3CL | EIF3D | EIF3E | EIF3EP1 | EIF3EP2 | EIF3F | EIF3FP2 | EIF3FP3 | EIF3G | EIF3H | EIF3I | EIF3IP1 | EIF3J | EIF3J-DT | EIF3K | EIF3KP1 | EIF3L | EIF3LP2 | EIF3LP3 | EIF3M | EIF4A1 | EIF4A1P4 | EIF4A2 | EIF4A2P4 | EIF4A2P5 | EIF4A3 | EIF4B | EIF4BP1 | EIF4BP3 | EIF4BP7 | EIF4BP9 | EIF4E | EIF4E1B | EIF4E2 | EIF4E3 | EIF4EBP1 | EIF4EBP2 | EIF4EBP3 | EIF4ENIF1 | EIF4F translation-initiation complex | EIF4G1 | EIF4G2 | EIF4G3 | EIF4H | EIF4HP2 | EIF5 | EIF5A | EIF5A2 | EIF5AL1 | EIF5B | EIF6 | EIPR1 | ELAC1 | ELAC2 | ELANE | ELAPOR1 | ELAPOR2 | Elastase | ELAVL1 | ELAVL2 | ELAVL3 | ELAVL4 | ELDR | ELF1 | ELF2 | ELF2P4 | ELF3 | ELF3-AS1 | ELF4 | ELF5 | ELFN1 | ELFN1-AS1 | ELFN2 | ELK1